Acute drug shortages are threatening the health care of millions of Americans at an escalating rate. Roughly 300 medications ...
Drug shortages are reaching near-record levels in the United States. There were 309 active drug shortages in the second ...
Ongoing drug shortages are forcing increased scrutiny around the power of federal regulators in supply chain management. Key drugs currently in shortage include cancer medications like cisplatin ...
Generic drugs are particularly vulnerable. According to the Food and Drug Administration, generic drugs account for over 70% ...
FORT MYERS, Fla. — Prescription drug shortages are nearing record levels across the nation, and the shortages are being felt by pharmacies and hospitals locally. Among the drugs in short supply ...
It's been 10 months since the Food and Drug Administration first announced a nationwide shortage of Adderall — and the supply strain could potentially worsen in the months ahead. Some experts ...
Parents across the US are beginning to face the struggles of a second winter without enough amoxicillin, the most prescribed antibiotic in the country.
Health experts say there is a national issue in the united states with a shortage of vital chemotherapy medicines that are ...
I've been working at PCMag since November 2016, covering all areas of technology and video game news. Before that I spent nearly 15 years working at Geek.com as a writer and editor. I also spent ...
Ongoing drug shortages are forcing increased scrutiny around the power of federal regulators in supply chain management. Key drugs currently in shortage include cancer medications like cisplatin ...
Ongoing drug shortages are forcing increased scrutiny around the power of federal regulators in supply chain management. Key drugs currently in shortage include cancer medications like cisplatin ...
Ongoing drug shortages are forcing increased scrutiny around the power of federal regulators in supply chain management. Key drugs currently in shortage include cancer medications like cisplatin ...
